A Tuesday quickie for all you fine roaches,
MCET (MultiCell technologies inc) just released some major news this morning stating “MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver disease. Under the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S. patent 7,935,528. “
Patents in itself can bring in the big dough, but a stem cell patent ?..mucho dinero, for sure. It doesn’t take a lot to see the potential of this, hence the stock already going up big time with over 160 million volume. For now, there seems to be some tugging going on from 0.012 to 0.015 (which in itself is a nice snipe play), however, it is trading very healthily with pullbacks and still has potential left, especially if it going to close strong at end of day. We all know lunch hour and power hour sometimes brings in some skyrocketing magic.
There’s some intraday support around 0.012..followed by 0.01. Strong resistance is at 0.0155, which it’s tried to cross a couple of times, but has not managed yet. Follow these levels closely, since it needs to break this resistance to have a good chance.
Disclosure: This corporate profile is provided for information purposes only and should not be used as the basis for any investment decision. We are neither licensed nor qualified to provide investment advice. We were not paid, nor do we hold a position in this stock. We reserve the right to buy or sell MCET at any time after this post.